Are you ready for the new reality for Life Sciences? Be part of the discussion.

KPMG is working with some of the smartest and most innovative players in the life sciences sector from around the world. We brought together some of these industry leaders for a series of virtual exchanges to hear from those who are having success, as well as to share perspectives, ideas and approaches. 

Connect with us

 

Want to do business with KPMG?

 

loading image Request for proposal

  

Explore the summit

Life sciences outlook: where do we go from here

Industry outlook

Larry Raff, Global Head of Life Sciences, KPMG in the US

Economic outlook

Yael Selfin, Chief Economist, KPMG in the UK

Outlook on tax

Andrea Tolley, Partner, Global Head of Life Sciences Tax, KPMG in the UK

Update on evolving US health and life sciences policy landscape

Larry Kocot, Head of US Healthcare Regulatory, KPMG in the US

A CEO’s perspective

Dan Hilferty, former CEO, Independence Health Group interviewed by Frank Mattei, Principal, Philadelphia Office Managing Partner, KPMG in the US

Making a difference in future care

Jeff Valliere, Head of Strategy, FasterCures, Milken Institute

Our role in improving healthcare around the world

Franck Perraudin, Head of Global Health Partnerships and Alliances, Sanofi interviewed by Chris Hardesty, Director and Life Sciences Leader for Asia Pacific, KPMG in Singapore

Outlook on healthcare

Dr. Anna van Poucke, Global Head of Healthcare, KPMG International

Responding to new markets: deals, alliances and M&A

Financing life sciences, Green Bonds, and outlook on capital markets

Bryan Byala, Senior Vice President and Treasurer, Brian McMahon, Vice President, Assistant Treasurer, Matthew Diamond, Capital Markets, Treasury Planning & Working Capital, Pfizer interview by Mary Rollman, Principal, Supply Chain and Operations Strategy, KPMG in the US

Innovation and where is venture capital flowing

John Boyce, Managing Director and Co-Founder, TigerGene, CEO of Nanomosaic, CEO of BrickBio, interviewed by Kristin Pothier, Principal, Global Healthcare and Life Sciences Strategy Leader, KPMG in the US

Update on deals and M&A in life sciences

Jeff Stoll, Principal, National Strategy Lead, Life Sciences, Kristin Pothier, Principal, Global Healthcare and Life Sciences Strategy Leader, KPMG in the US

Digital prescription to a healthy future

The positive impact will have on the industry

Jeanne Kehren, SVP Digital & Commercial Innovation & CIO, Bayer Pharmaceuticals interview by Thomas Hillek, Partner, Head of European Life Sciences, KPMG in Germany

The power of digital transformation on lives

James Chiang, Vice President, Diabetes Care, Becton Dickinson interviewed by Chris Hardesty, Director and Life Sciences Leader for Asia Pacific, KPMG in Singapore

Digital transformation and life sciences, KPMG’s perspective

Justin Hoss, Principal, Life Sciences Technology Industry Leader, KPMG in the US and Arun Ghosh, Principal, Life Sciences Management Consulting Technology Engagement, KPMG in the US

Digitalization in life sciences, a Chinese perspective

Pius Hornstein, General Manager & Country Lead, Sanofi China interview by Mark Harrison, Partner, KPMG in China

Keys to digital transformation

Desmond Creary, Health Business Leader of the Americas, Microsoft interview by Mark Gorvin, Director, Life Sciences Global Alliances Lead, KPMG in the US

Insights into a digital transformation

Andy Croft, Vice President, Enterprise Excellence, CSL Behring interviewed by Rick Cimino, Partner, Enterprise Solution Leader, KPMG in the US

The enlightened and digitally enabled operation: is it possible?

Integrating innovation; managing through a merger

Fraser MacFarlane, Vice President, R&D Implementation Lead, and Steve Pessagno, Alliance Director & Head of Global Alliance Management Operations, GSK interviewed by Mark Harper, Partner, KPMG in the UK

Opportunities and innovation born out of digitalization

Anjana Harve, Global Chief Information Officer, Fresenius Medical Care interviewed by Rajesh Misera, Principal, Advisory, KPMG in the US

Putting the patient first

Tanisha Carino, EVP, Chief Corporate Affairs, Alexion Pharmaceuticals interviewed by Alasdair Milton, Managing Director, Advisory, KPMG in the US

Advancing personalized care

Michael Barthold, Director of R&D, Depuy Synthes (J&J Medical Devices) interviewed by Jerry Iacouzzi, Principal, Supply Chain and Operations, KPMG in the US

Digitalization of operations, KPMG perspective

Mary Rollman, Principal, Deal Advisory and Operations Strategy, KPMG in the US and Roger Van den Heuvel, Principal, Strategy KPMG in the US
DNA molecule

Life Sciences

Our team is dedicated to assisting businesses of all sizes.

Discover